Emile Radyte

Emile Radyte, PhD is a Harvard & Oxford-trained neuroscientist, the co-founder and CEO of Samphire Neuroscience. She has been named on the Forbes 30 under 30 (Healthcare, 2024) list for her work in developing  Nettle, the 2024 Medical Innovation of the Year (Medica) that is the only medically-certified therapeutic device that reduces pain and improves PMS in women of reproductive age that has already changed the lives for thousands of women. Prior to Samphire, she led Harvard’s emergency medical service (90 medics), and co-founded and led Lithuania’s largest neuroscience NGO, Integrative Neuroscience Association, with a team of 40+.